安图生物及子公司获得医疗器械注册证

Core Viewpoint - Antu Biology (603658.SH) has received medical device registration certificates from the National Medical Products Administration and the Henan Provincial Medical Products Administration, enhancing its product offerings and competitiveness in the market [1] Group 1: Company Developments - The company and its wholly-owned subsidiary, Zhengzhou Sikun Biological Engineering Co., Ltd., along with its secondary subsidiary, Zhengzhou Biaoyuan Biotechnology Co., Ltd., have recently obtained medical device registration certificates [1] - The acquisition of these certificates enriches the company's product menu and meets market demand, serving as an effective supplement to existing testing products [1] Group 2: Market Impact - The new medical device registration is expected to gradually improve the overall competitiveness of the company's products [1] - The short-term impact on the company's operating performance is considered to be minimal [1]